Share Price and Basic Stock Data
Last Updated: November 22, 2025, 11:05 am
| PEG Ratio | 0.56 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cochin Minerals & Rutile Ltd operates in the chemicals sector, specifically in inorganic chemicals, and reported a market capitalization of ₹209 Cr. The company’s stock price stood at ₹266, and it recorded a trailing twelve months (TTM) revenue of ₹281 Cr. over the last fiscal year, which reflects a decline from ₹444 Cr. in Mar 2023. The revenue trend shows significant fluctuations; for instance, sales peaked at ₹119.04 Cr. in Dec 2022 but dropped to ₹50.69 Cr. in Sep 2023. This decline is concerning, especially when comparing it to the strong performance in prior periods. The company’s sales in Mar 2025 are projected to be ₹319 Cr., indicating a recovery from the recent downturn. However, the revenue’s volatility highlights potential challenges in maintaining consistent growth, which is crucial in the competitive chemicals market.
Profitability and Efficiency Metrics
The profitability metrics for Cochin Minerals & Rutile Ltd indicate a mixed performance. The operating profit margin (OPM) declined to 4.01% as of Jun 2025, down from a high of 19.39% in Sep 2022. This decline suggests that the company has faced rising costs or pricing pressures that have impacted profitability. The net profit for Mar 2025 stood at ₹24 Cr., a recovery from a loss of ₹6.92 Cr. in Mar 2024. The interest coverage ratio is exceptionally high at 192.59x, showcasing the company’s ability to meet interest obligations comfortably. However, the cash conversion cycle (CCC) of 239 days indicates inefficiencies in managing working capital, with high inventory days at 400, which can strain liquidity. The combination of declining margins and high CCC represents a significant challenge to operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Cochin Minerals & Rutile Ltd reveals a low debt profile, with total debt to equity ratio at 0.06, suggesting a conservative capital structure. The company reported a return on equity (ROE) of 15.0% and a return on capital employed (ROCE) of 23.3%, which are relatively strong indicators of profitability compared to industry standards. The book value per share has shown a consistent increase, reaching ₹211.23 in Mar 2025, indicating a solid capital base. However, the absence of reserves and borrowings raises questions about its financial flexibility during downturns. The current ratio of 2.35 indicates sound liquidity, while the quick ratio of 0.58 suggests potential liquidity challenges in meeting short-term obligations. Overall, while the company exhibits strong profitability ratios, its balance sheet lacks reserves, which could hinder growth opportunities.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cochin Minerals & Rutile Ltd shows a stable promoter holding of 51.17%, which reflects strong internal confidence in the company’s management and strategy. The foreign institutional investors (FIIs) have not been reported, while domestic institutional investors (DIIs) hold a minimal stake of 0.07%. Public ownership stands at 48.75%, with a growing number of shareholders reported at 14,248. This increase from 9,347 in Dec 2022 suggests rising interest among retail investors, signaling confidence in the company’s prospects. However, the low institutional ownership may limit the stock’s visibility and support in the market. The stable promoter holding alongside increasing public interest could be a positive signal for potential investors looking for long-term growth.
Outlook, Risks, and Final Insight
The outlook for Cochin Minerals & Rutile Ltd appears cautiously optimistic, given its recovery in net profit and strong interest coverage ratio. However, the recent volatility in sales and declining profitability metrics pose significant risks. The high cash conversion cycle indicates potential inefficiencies that could affect liquidity, especially if market conditions remain challenging. The company’s lack of reserves could limit its ability to invest in growth opportunities or weather economic downturns. Stakeholders should monitor the company’s operational efficiency closely, as improvements in inventory management and cost control could enhance profitability. Future growth may hinge on the company’s ability to stabilize revenue streams and enhance operational performance amidst a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cochin Minerals & Rutile Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,647 Cr. | 41.0 | 125/40.8 | 132 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 16.2 Cr. | 32.4 | 48.3/25.8 | 70.3 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 207 Cr. | 264 | 410/238 | 12.4 | 211 | 3.03 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,673 Cr. | 541 | 730/408 | 32.6 | 157 | 0.55 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 347 Cr. | 444 | 536/376 | 16.9 | 144 | 0.68 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,953.50 Cr | 585.58 | 180.01 | 160.00 | 0.49% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99.17 | 117.88 | 119.04 | 107.83 | 66.76 | 50.69 | 82.16 | 100.82 | 88.35 | 89.73 | 65.58 | 75.41 | 75.14 |
| Expenses | 88.44 | 95.02 | 99.94 | 88.79 | 63.86 | 46.04 | 68.66 | 83.99 | 79.61 | 79.19 | 58.50 | 71.03 | 72.13 |
| Operating Profit | 10.73 | 22.86 | 19.10 | 19.04 | 2.90 | 4.65 | 13.50 | 16.83 | 8.74 | 10.54 | 7.08 | 4.38 | 3.01 |
| OPM % | 10.82% | 19.39% | 16.05% | 17.66% | 4.34% | 9.17% | 16.43% | 16.69% | 9.89% | 11.75% | 10.80% | 5.81% | 4.01% |
| Other Income | 0.00 | 0.12 | 1.72 | 2.04 | 0.77 | 0.30 | 1.68 | 0.10 | 0.60 | 1.63 | 1.37 | 4.75 | 2.43 |
| Interest | 0.16 | 0.68 | 0.16 | 0.31 | 0.08 | 0.21 | 0.42 | 0.12 | 0.10 | 0.03 | 0.02 | 0.06 | 0.07 |
| Depreciation | 0.21 | 0.23 | 0.23 | 0.26 | 0.17 | 0.21 | 0.20 | 0.27 | 0.24 | 0.27 | 0.28 | 0.34 | 0.29 |
| Profit before tax | 10.36 | 22.07 | 20.43 | 20.51 | 3.42 | 4.53 | 14.56 | 16.54 | 9.00 | 11.87 | 8.15 | 8.73 | 5.08 |
| Tax % | 18.53% | 17.54% | 17.72% | 36.67% | 33.63% | 30.24% | 30.77% | 141.90% | 33.89% | 40.44% | 38.28% | 36.66% | 35.63% |
| Net Profit | 8.44 | 18.18 | 16.81 | 13.00 | 2.27 | 3.17 | 10.08 | -6.92 | 5.95 | 7.06 | 5.02 | 5.52 | 3.27 |
| EPS in Rs | 10.78 | 23.22 | 21.47 | 16.60 | 2.90 | 4.05 | 12.87 | -8.84 | 7.60 | 9.02 | 6.41 | 7.05 | 4.18 |
Last Updated: August 19, 2025, 9:00 pm
Below is a detailed analysis of the quarterly data for Cochin Minerals & Rutile Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 75.14 Cr.. The value appears to be declining and may need further review. It has decreased from 75.41 Cr. (Mar 2025) to 75.14 Cr., marking a decrease of 0.27 Cr..
- For Expenses, as of Jun 2025, the value is 72.13 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.03 Cr. (Mar 2025) to 72.13 Cr., marking an increase of 1.10 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.01 Cr.. The value appears to be declining and may need further review. It has decreased from 4.38 Cr. (Mar 2025) to 3.01 Cr., marking a decrease of 1.37 Cr..
- For OPM %, as of Jun 2025, the value is 4.01%. The value appears to be declining and may need further review. It has decreased from 5.81% (Mar 2025) to 4.01%, marking a decrease of 1.80%.
- For Other Income, as of Jun 2025, the value is 2.43 Cr.. The value appears to be declining and may need further review. It has decreased from 4.75 Cr. (Mar 2025) to 2.43 Cr., marking a decrease of 2.32 Cr..
- For Interest, as of Jun 2025, the value is 0.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Mar 2025) to 0.07 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.29 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.34 Cr. (Mar 2025) to 0.29 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.08 Cr.. The value appears to be declining and may need further review. It has decreased from 8.73 Cr. (Mar 2025) to 5.08 Cr., marking a decrease of 3.65 Cr..
- For Tax %, as of Jun 2025, the value is 35.63%. The value appears to be improving (decreasing) as expected. It has decreased from 36.66% (Mar 2025) to 35.63%, marking a decrease of 1.03%.
- For Net Profit, as of Jun 2025, the value is 3.27 Cr.. The value appears to be declining and may need further review. It has decreased from 5.52 Cr. (Mar 2025) to 3.27 Cr., marking a decrease of 2.25 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.18. The value appears to be declining and may need further review. It has decreased from 7.05 (Mar 2025) to 4.18, marking a decrease of 2.87.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 131 | 116 | 158 | 149 | 164 | 223 | 263 | 239 | 290 | 444 | 300 | 319 | 281 |
| Expenses | 131 | 137 | 171 | 149 | 155 | 208 | 241 | 219 | 281 | 372 | 262 | 288 | 265 |
| Operating Profit | -0 | -21 | -13 | -0 | 9 | 16 | 22 | 20 | 9 | 72 | 39 | 31 | 16 |
| OPM % | -0% | -19% | -8% | -0% | 6% | 7% | 8% | 9% | 3% | 16% | 13% | 10% | 6% |
| Other Income | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 0 | 0 | 4 | 3 | 8 | 11 |
| Interest | 4 | 8 | 6 | 7 | 7 | 6 | 3 | 2 | 1 | 2 | 2 | 1 | 0 |
| Depreciation | 2 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -5 | -33 | -21 | -8 | 2 | 11 | 20 | 18 | 8 | 73 | 39 | 38 | 26 |
| Tax % | -24% | -35% | -34% | -29% | 39% | 51% | 70% | 54% | 18% | 23% | 78% | 38% | |
| Net Profit | -4 | -22 | -14 | -6 | 1 | 5 | 6 | 8 | 6 | 56 | 9 | 24 | 17 |
| EPS in Rs | -4.96 | -27.47 | -17.93 | -7.32 | 1.71 | 6.99 | 7.65 | 10.36 | 7.93 | 72.07 | 10.97 | 30.09 | 21.41 |
| Dividend Payout % | -20% | 0% | 0% | 0% | 0% | 0% | 26% | 0% | 19% | 11% | 73% | 27% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -450.00% | 36.36% | 57.14% | 116.67% | 400.00% | 20.00% | 33.33% | -25.00% | 833.33% | -83.93% | 166.67% |
| Change in YoY Net Profit Growth (%) | 0.00% | 486.36% | 20.78% | 59.52% | 283.33% | -380.00% | 13.33% | -58.33% | 858.33% | -917.26% | 250.60% |
Cochin Minerals & Rutile Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 4% |
| 3 Years: | 3% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 32% |
| 3 Years: | 56% |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 19% |
| 3 Years: | 15% |
| 1 Year: | -7% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 17% |
| 3 Years: | 21% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:01 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50 | 38 | 20 | 20 | 32 | 12 | 22 | 40 | 37 | 20 | 43 | 19 |
| Inventory Days | 491 | 451 | 306 | 216 | 380 | 223 | 172 | 82 | 115 | 62 | 328 | 400 |
| Days Payable | 124 | 134 | 132 | 62 | 166 | 114 | 192 | 50 | 181 | 21 | 211 | 180 |
| Cash Conversion Cycle | 418 | 355 | 194 | 173 | 245 | 121 | 2 | 72 | -29 | 61 | 160 | 239 |
| Working Capital Days | 152 | 139 | 43 | 19 | 22 | 11 | 31 | 67 | 34 | 51 | 111 | 114 |
| ROCE % | -1% | -16% | -12% | -1% | 9% | 16% | 24% | 23% | 9% | 62% | 27% | 23% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 30.09 | 10.98 | 72.07 | 7.93 | 10.36 |
| Diluted EPS (Rs.) | 30.09 | 10.98 | 72.07 | 7.93 | 10.36 |
| Cash EPS (Rs.) | 31.54 | 12.07 | 73.26 | 9.24 | 11.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 211.23 | 189.58 | 186.85 | 116.92 | 109.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 211.23 | 189.58 | 186.85 | 116.92 | 109.04 |
| Dividend / Share (Rs.) | 8.00 | 8.00 | 8.00 | 1.50 | 0.00 |
| Revenue From Operations / Share (Rs.) | 407.49 | 383.70 | 566.94 | 370.07 | 305.43 |
| PBDIT / Share (Rs.) | 49.91 | 52.03 | 96.57 | 11.18 | 25.79 |
| PBIT / Share (Rs.) | 48.46 | 50.94 | 95.37 | 9.86 | 24.31 |
| PBT / Share (Rs.) | 48.20 | 49.86 | 93.70 | 9.64 | 22.52 |
| Net Profit / Share (Rs.) | 30.09 | 10.98 | 72.06 | 7.93 | 10.36 |
| PBDIT Margin (%) | 12.24 | 13.55 | 17.03 | 3.01 | 8.44 |
| PBIT Margin (%) | 11.89 | 13.27 | 16.82 | 2.66 | 7.95 |
| PBT Margin (%) | 11.82 | 12.99 | 16.52 | 2.60 | 7.37 |
| Net Profit Margin (%) | 7.38 | 2.86 | 12.71 | 2.14 | 3.39 |
| Return on Networth / Equity (%) | 14.24 | 5.78 | 38.56 | 6.78 | 9.49 |
| Return on Capital Employeed (%) | 22.13 | 25.39 | 48.52 | 8.17 | 21.66 |
| Return On Assets (%) | 8.87 | 3.57 | 30.81 | 3.47 | 6.98 |
| Long Term Debt / Equity (X) | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.06 | 0.03 | 0.03 | 0.00 | 0.07 |
| Asset Turnover Ratio (%) | 1.26 | 1.42 | 2.45 | 1.96 | 1.77 |
| Current Ratio (X) | 2.35 | 2.37 | 4.83 | 1.62 | 2.60 |
| Quick Ratio (X) | 0.58 | 0.99 | 3.57 | 1.02 | 1.70 |
| Inventory Turnover Ratio (X) | 2.27 | 2.16 | 4.73 | 4.51 | 2.35 |
| Dividend Payout Ratio (NP) (%) | 26.58 | 72.88 | 2.08 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 25.36 | 66.28 | 2.04 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 73.42 | 27.12 | 97.92 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 74.64 | 33.72 | 97.96 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 192.59 | 48.54 | 57.83 | 50.90 | 14.37 |
| Interest Coverage Ratio (Post Tax) (X) | 117.11 | 11.24 | 44.16 | 37.13 | 6.77 |
| Enterprise Value (Cr.) | 182.91 | 193.87 | 169.38 | 57.87 | 94.88 |
| EV / Net Operating Revenue (X) | 0.57 | 0.64 | 0.38 | 0.19 | 0.39 |
| EV / EBITDA (X) | 4.68 | 4.76 | 2.24 | 6.61 | 4.70 |
| MarketCap / Net Operating Revenue (X) | 0.62 | 0.70 | 0.48 | 0.28 | 0.37 |
| Retention Ratios (%) | 73.41 | 27.11 | 97.91 | 0.00 | 0.00 |
| Price / BV (X) | 1.21 | 1.42 | 1.47 | 0.90 | 1.05 |
| Price / Net Operating Revenue (X) | 0.62 | 0.70 | 0.48 | 0.28 | 0.37 |
| EarningsYield | 0.11 | 0.04 | 0.26 | 0.07 | 0.09 |
After reviewing the key financial ratios for Cochin Minerals & Rutile Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 30.09. This value is within the healthy range. It has increased from 10.98 (Mar 24) to 30.09, marking an increase of 19.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is 30.09. This value is within the healthy range. It has increased from 10.98 (Mar 24) to 30.09, marking an increase of 19.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 31.54. This value is within the healthy range. It has increased from 12.07 (Mar 24) to 31.54, marking an increase of 19.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.23. It has increased from 189.58 (Mar 24) to 211.23, marking an increase of 21.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.23. It has increased from 189.58 (Mar 24) to 211.23, marking an increase of 21.65.
- For Dividend / Share (Rs.), as of Mar 25, the value is 8.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 8.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 407.49. It has increased from 383.70 (Mar 24) to 407.49, marking an increase of 23.79.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 49.91. This value is within the healthy range. It has decreased from 52.03 (Mar 24) to 49.91, marking a decrease of 2.12.
- For PBIT / Share (Rs.), as of Mar 25, the value is 48.46. This value is within the healthy range. It has decreased from 50.94 (Mar 24) to 48.46, marking a decrease of 2.48.
- For PBT / Share (Rs.), as of Mar 25, the value is 48.20. This value is within the healthy range. It has decreased from 49.86 (Mar 24) to 48.20, marking a decrease of 1.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 30.09. This value is within the healthy range. It has increased from 10.98 (Mar 24) to 30.09, marking an increase of 19.11.
- For PBDIT Margin (%), as of Mar 25, the value is 12.24. This value is within the healthy range. It has decreased from 13.55 (Mar 24) to 12.24, marking a decrease of 1.31.
- For PBIT Margin (%), as of Mar 25, the value is 11.89. This value is within the healthy range. It has decreased from 13.27 (Mar 24) to 11.89, marking a decrease of 1.38.
- For PBT Margin (%), as of Mar 25, the value is 11.82. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 11.82, marking a decrease of 1.17.
- For Net Profit Margin (%), as of Mar 25, the value is 7.38. This value is within the healthy range. It has increased from 2.86 (Mar 24) to 7.38, marking an increase of 4.52.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.24. This value is below the healthy minimum of 15. It has increased from 5.78 (Mar 24) to 14.24, marking an increase of 8.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.13. This value is within the healthy range. It has decreased from 25.39 (Mar 24) to 22.13, marking a decrease of 3.26.
- For Return On Assets (%), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 3.57 (Mar 24) to 8.87, marking an increase of 5.30.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.26. It has decreased from 1.42 (Mar 24) to 1.26, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 2.35. This value is within the healthy range. It has decreased from 2.37 (Mar 24) to 2.35, marking a decrease of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 24) to 0.58, marking a decrease of 0.41.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.27. This value is below the healthy minimum of 4. It has increased from 2.16 (Mar 24) to 2.27, marking an increase of 0.11.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 26.58. This value is within the healthy range. It has decreased from 72.88 (Mar 24) to 26.58, marking a decrease of 46.30.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 25.36. This value is within the healthy range. It has decreased from 66.28 (Mar 24) to 25.36, marking a decrease of 40.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 73.42. This value exceeds the healthy maximum of 70. It has increased from 27.12 (Mar 24) to 73.42, marking an increase of 46.30.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 74.64. This value exceeds the healthy maximum of 70. It has increased from 33.72 (Mar 24) to 74.64, marking an increase of 40.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 192.59. This value is within the healthy range. It has increased from 48.54 (Mar 24) to 192.59, marking an increase of 144.05.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 117.11. This value is within the healthy range. It has increased from 11.24 (Mar 24) to 117.11, marking an increase of 105.87.
- For Enterprise Value (Cr.), as of Mar 25, the value is 182.91. It has decreased from 193.87 (Mar 24) to 182.91, marking a decrease of 10.96.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.57, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has decreased from 4.76 (Mar 24) to 4.68, marking a decrease of 0.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 24) to 0.62, marking a decrease of 0.08.
- For Retention Ratios (%), as of Mar 25, the value is 73.41. This value exceeds the healthy maximum of 70. It has increased from 27.11 (Mar 24) to 73.41, marking an increase of 46.30.
- For Price / BV (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.21, marking a decrease of 0.21.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 24) to 0.62, marking a decrease of 0.08.
- For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.11, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cochin Minerals & Rutile Ltd:
- Net Profit Margin: 7.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.13% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.24% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 117.11
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.58
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.4 (Industry average Stock P/E: 163.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | P.B. No. 73, Aluva Kerala 683101 | cmrlexim@cmrlindia.com http://www.cmrlindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R K Garg | Chairman |
| Mr. Saran S Kartha | Managing Director |
| Mr. Anil Ananda Panicker | Executive Director |
| Mr. Mathew M Cherian | Director |
| Mr. V Vinod Kamath | Director |
| Mrs. Jaya S Kartha | Director |
| Mr. Nabiel Mathew Cherian | Director |
| Mr. S Yogindunath | Director |
| Mr. Venkitraman Anand | Director |
| Dr. Rabinarayan Patra | Director |
| Mr. R Hari Krishnan | Director |